N@N

NOKOMIS, Fla.--([ BUSINESS WIRE ])--After a brief reorganization, Rainbow Coral Corp.as (OTCBB: RBCC) biotech subsidiary, Rainbow Biosciences, has announced plans to follow through on three new deals for the company this quarter.

In a continuing effort to build shareholder value, RBCC will work toward closing three biotechnology projects in the next few months, with the expectation to close one before the end of the quarter.

The companyas current deal flow includes work with RBCCas current partners and investment targets on new marketing initiatives as well as two new deals the company is excited to announce soon. RBCC has prioritized the commercialization of new innovations in stem cell research, cell culturing and the diagnosis and treatment of deadly neurological diseases.

Rainbow BioSciences is working to develop new medical and research technology innovations to compete alongside companies such as Cell Therapeutics, Inc. (NASDAQ:CTIC),Biogen Idec Inc. (NASDAQ:BIIB) and Elan Corp. (NYSE:ELN).

For more information on Rainbow BioSciences, RBCCas biotechnology division, please visit [ www.rainbowbiosciences.com/investors.html ].

About Rainbow BioSciences

Rainbow BioSciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (OTCBB:RBCC). The company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit our website at [[ www.RainbowBioSciences.com ]]. For investment information and performance data on the company, please visit [ www.RainbowBioSciences.com/investors.html ].

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.